23h
Hosted on MSNModerna (MRNA) Reports Q4 Loss, Tops Revenue EstimatesModerna (MRNA) came out with a quarterly loss of $2.50 per share versus the Zacks Consensus Estimate of a loss of $2.69. This compares to earnings of $0.55 per share a year ago. These figures are ...
Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.04 per share a year ago. These ...
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
The MS and PhD programs in Genetics, Genomics and Bioinformatics (GGB) prepare students to contribute to exciting new research essential to the success of 21st-century medicine, novel treatments and ...
Having a parent or sibling with diabetes does mean you are more likely to develop it yourself. But diabetes isn't just caused by genetics. Having a relative with the disease doesn't guarantee you will ...
SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
The College of Biomedical and Life Sciences is a vibrant academic community, which undertakes innovative research and provides state-of-the-art learning facilities. Researchers from Cardiff University ...
The Stanford Center for Biomedical Ethics (SCBE ... The center works on AI technologies, rare and undiagnosed diseases, genetics and education research, ethical issues in healthcare and health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results